TEVA Related Rumors
-
UPDATE: PROLOR Biotech (PBTH) not in sale talks
-
Options Whittling Down for Endo Health (ENDP) as CEO Holveck Departs
-
Amarin (AMRN) Higher as Teva (TEVA) Said to be Waiting in the Wings for a Takeover
-
Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
-
Par Pharmaceutical (PRX) Peers On Watch After Deal (TEVA) (MYL) (WPI)
-
Watson Pharma (WPI) May Pay $6B for Mysterious Swiss Drug Maker
-
Canaccord Genuity on Life Sciences/Specialty Pharma: What an Actavis Deal Could Mean to Watson (WPI) and the Sector
-
Teva (TEVA) Wins FDA Approval for First Generic Version of Forest Labs' (FRX) Lexapro for Depression -Bloomberg
-
BioSante (BPAX), Teva (TEVA) Receive FDA Approval for Bio-T-Gel -Bloomberg
-
Teva (TEVA) Could Recall a Batch of Treanda -WSJ
-
Hospira (HSP) May Find Itself a Takeover Target
-
EU Ready to Clear Teva/Cephalon Deal -Reuters (TEVA) (CEPH)
-
Wall Street Expecting Delays to Antitrust Clearance for Cephalon/Teva Deal (CEPH) (TEVA)
-
Valeant Pharmaceuticals (VRX) Slammed After Losing Cephalon (CEPH) Bidding
-
Reports Teva (TEVA) Beat Out Pfizer (PFE) to Acquire Ratiopharm for $4.78B
-
Pfizer (PFE) Nears Bid for Ratiopharm
-
Protalix (PLX) Sells-Off On Pfizer News, As Fast Money Disappointed In No Takeover
-
Protalix BioTherapeutics (PLX) Sees Interest On Renewed Takeover Talk
-
Now Pfizer Is Rumored To Be Interested In Protalix (PLX)
-
Protalix Biotherapeutics (PLX) Up On Takeover Speculation
-
Watson Pharmaceuticals (WPI) Mentioned As Takeover Target on CNBC
-
Wachovia Comments on Mylan (MYL) After TEVA/BRL Merger
-
Teva (TEVA) in talks to buy Barr Pharmaceuticals Inc. (BRL) for about $7 billion - WSJ
-
Barr Pharma (BRL) Higher On Reports Teva (TEVA) Could Buy The Company
-
Endo Pharmaceuticals (ENDP) Higher on Takeover Speculation
-
WR Hambrecht Comments on Teva (TEVA) Takeover Targets, Is IPXL in Play?
-
Reports Teva Pharmaceutical (TEVA) CEO to Resign
-
WSJ Reports Merck (MRK) is Taking Steps to Aggressively Price Zocor Below Teva Pharma's (TEVA) Generic Version
-
Citigroup offers six predictions for specialty pharma in 2006
-
IVD Could Be 'In-Play' After IVX/TEVA Merger Deal
-
IPXLE and ADRX Could See Interest on Industry Trend in Generic Sector After TEVA/IVX Deal
-
TEVA Confirms IVX Acquisition
-
TEVA Close To Deal to Buy IVX - NY Times
-
MNTA Higher, SNY Lower After Judgment on Generic Lovenox
-
TEVA, IVX and RDY Stand To Benefit If Court Rules Against LLY on Zyprexa
-
BusinessWeek Highlights IPXL as Takeover Target
-
TEVA and SRA higher after BIIB/ELN Tysabri News
Back to TEVA Stock Lookup
